Skip to main content

Select Drug Profiles

A Silver Anniversary of the Internet

David B. Nash, MD, MBA

Original Research

Cardiovascular-Related Healthcare Resource Utilization and Costs in Patients with Hypertension Switching from Metoprolol to Nebivolol

Stephanie Chen, PhD, An-Chen Fu, MS, BSPharm, Rahul Jain, PhD, Hiangkiat Tan, MS, BSPharm

Stakeholder Perspective

Moving Beyond Measures into Outcomes in Hypertension Research

by Michael F. Murphy, MD, PhD

Practice Management

Economic Burden of Opioid-Induced Constipation Among Long-Term Opioid Users with Noncancer Pain

Shelby Corman, PharmD, MS, BCPS, Xin Gao, PhD, Sizhu Liu, MS, Reema Mody, PhD,MBA, Haridarshan Patel, PharmD, Yin Wan, MS, BSPharm

Stakeholder Perspective

Opioid-Induced Constipation Associated with Considerable Economic Burden

by Matthew Mitchell, PharmD, MBA, FAMCP

Practice Management

The Cost of Unintended Pregnancies for Employer-Sponsored Health Insurance Plans

Gabriela Dieguez, FSA, MAAA, Amy W. Law, PharmD, Richard Lynen, MD, James Trussell, PhD, Bruce S. Pyenson, FSA, MAAA

Stakeholder Perspective

A Call to Action to Address Burden of Unintended Pregnancies in Plans’ Benefit Design

by F. Randy Vogenberg, PhD, FASHP

Multiple Myeloma, Oncology

Pomalidomide plus Low-Dose Dexamethasone Combination Likely to Be Cost-Effective

The Value of Pharmaceuticals and Adherence to Therapy in the Management of Hematologic Cancers

Atheer A. Kaddis, PharmD

Leukemia, Oncology

Brentuximab Cost-Effective After Transplant

Stem-Cell Transplant Safe in HIV-Related Lymphoma

Posttransplant Brentuximab: New Standard in Hodgkin Lymphoma?

Leukemia, Oncology

Pediatric Regimen a New Standard for Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Page 133 of 244
Results 1321 - 1330 of 2438